Effect of alendronate on bone mineral density in male idiopathic osteoporosis

Metabolism: Clinical and Experimental

Volumn 50, Issue 8, 2001, Pages 912-915

  Weber, T J ^a   Drezner, M K ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCITRIOL; CALCIUM; ETIDRONIC ACID; FLUORIDE SODIUM; VITAMIN D;

ADULT; ANALYTIC METHOD; ARTICLE; BONE DENSITY; BONE MINERAL; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; HIP FRACTURE; HUMAN; LABORATORY TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINE FRACTURE; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

EID: 0034879128     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.24925     Document Type: Article

References (24)

1. Vertebral deformity in men
2. Effects of age and sex on bone density at the hip and spine in a normal Caucasian New Zealand population
3. Longitudinal measurement of regional and whole body bone mass in young healthy adults
4. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation
5. Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study
6. Hip fractures in the elderly: A world-wide projection
7. Risk factors for osteoporotic fractures in elderly men
8. Hip fractures among the elderly: Factors associated with in-hospital mortality
9. Pathogenesis of vertebral crush fractures in men
10. Severe osteoporosis in men
11. Insulin-like growth factor-I in men with idiopathic osteoporosis
12. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
13. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
14. Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation
15. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures
16. Effect of alendronate treatment on bone mineral density in male patients with osteoporosis
17. Aetiology and presenting symptoms in male osteoporosis
18. Effect of thiazide on rates of bone mineral loss: A longitudinal study
19. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group
20. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
21. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group
22. Risedronate therapy prevents corticosteroid-induced bone loss: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
23. Effects of alendronate on bone density in men with primary and secondary osteoporosis
24. Alendronate for the treatment of osteoporosis in men